BWXT Medical and NorthStar Medical Radioisotopes Sign Supply Agreement Supporting Actinium-225 Production July 22, 2024
BWXT to Evaluate Locations for Building New Nuclear TRISO Fuel Production Facility to Support Advanced Reactor Deployment July 18, 2024
BWXT-led Team Awarded $30 Billion Management and Operating Contract for National Nuclear Security Administration’s Pantex Plant June 14, 2024
BWXT Medical Submits Drug Master File for Actinium-225 API to U.S. Food and Drug Administration June 7, 2024
BWXT Announces Expansion of Cambridge Manufacturing Plant to Support Global Nuclear Power Market April 19, 2024
